User: I want to come up with a molecule SMILES.
Assistant: This sounds very exciting. Should it be a special molecule?
User: Yes, the molecule should have a half life time in humans after IV administration value close to 51.000 hours.
Assistant: Got it, this SMILES has a half life time in humans after IV administration value of approximately 51.000 hours: CCCCCC/C=C\CCCCCCCCCC(=O)N[C@H]1[C@H](OC[C@H]2O[C@H](OP(=O)(O)O)[C@H](NC(=O)CC(=O)CCCCCCCCCCC)[C@@H](OCCCCCCCCCC)[C@@H]2O)O[C@H](COC)[C@@H](OP(=O)(O)O)[C@@H]1OCC[C@@H](CCCCCCC)OC
User: I want to {#come up with|create|generate!} a {#molecule |!}{SMILES__description}.
Assistant: {#This sounds very exciting. |This sounds very interesting. !}Should it be a special {#molecule|one!}?
User: Yes, the molecule should have a {half_life_duration__names__noun} value close to {half_life_duration#} {half_life_duration__units}.
Assistant: {#Understood|Got it|Ok!}, this {SMILES__description} has a {half_life_duration__names__noun} value of approximately {half_life_duration#} {half_life_duration__units}: {SMILES#}
[(2R,3R,4R,5S,6R)-4-decoxy-5-hydroxy-6-[[(2R,3R,4R,5S,6R)-4-[(3R)-3-methoxydecoxy]-6-(methoxymethyl)-3-[[(Z)-octadec-11-enoyl]amino]-5-phosphonooxyoxan-2-yl]oxymethyl]-3-(3-oxotetradecanoylamino)oxan-2-yl] dihydrogen phosphate